Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 23NIH 2UNKNOWN 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Meningeal Carcinomatosis 2Brain Neoplasms 2Thoracic Neoplasms 1Stomach Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

icotinib 2Erlotinib Hydrochloride 2pembrolizumab 1camrelizumab 1aumolertinib 1apatinib 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Pemetrexed 1Gemcitabine 1Gefitinib 1Drug Therapy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Carcinoma, Non-Small-Cell Lung × Radiotherapy, Intensity-Modulated × Clear all
NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

ChineseAMS

Phase 3 Completed
394 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡